- Home
- ONFO vs CANF Comparison
ONFO vs CANF Comparison
Compare ONFO & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONFO | CANF |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 3.5M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ONFO | CANF |
|---|---|---|
| Price | $0.73 | $3.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9,750.00 |
| AVG Volume (30 Days) | 67.3K | ★ 557.0K |
| Earning Date | 11-17-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,238,989.00 | $560,000.00 |
| Revenue This Year | N/A | $461.72 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 70.54 | N/A |
| 52 Week Low | $0.59 | $3.36 |
| 52 Week High | $1.95 | $46.60 |
Technical Indicators
Market Signals| Indicator | ONFO | CANF |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 72.72 |
| Support Level | $0.70 | $4.01 |
| Resistance Level | $0.85 | $4.43 |
| Average True Range (ATR) | 0.07 | 0.31 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 52.31 | 80.99 |
Price Performance
Historical ComparisonAbout ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.